POZ - Latino Hub : Treatment News : New Drug Fights HIV and Many Other Viruses

POZ Latino / Hispanic Hub
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:
 

Back to home » News & Views » Treatment News


 

March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007


emailrssprint

February 3, 2010

New Drug Fights HIV and Many Other Viruses

Researchers found a new antiviral drug that appears to effectively target not only HIV, but also Ebola, influenza and Rift Valley fever, according to a study published online January 28 in the Proceedings of the National Academy of Sciences.

Researchers have been increasingly focused on finding antibiotics called “broad spectrum” antibiotics, which are effective against many different types of bacteria. Thus far, however, few broad spectrum antivirals have been discovered. Most available antiviral drugs tend to be effective against only one disease or a particular family of viruses.

LJ001, discovered by researchers at the University of California in Los Angeles (UCLA), the University of Texas at Galveston, Harvard University, Cornell University and the Army Medical Research Institute of Infectious Diseases, may be one such broad spectrum antiviral. Derived from an acidic chemical called rhodanine, it was uncovered by sifting through a library of more than 30,000 compounds.

LJ001 appears, thus far, to be effective against a host of viruses, including HIV, influenza A and Ebola. UCLA will patent the compound.

As the researchers were testing LJ001, they realized it was effective only against viruses with fatty membranes that interact with human cells. LJ001 also appears harmful to cell membranes, but cell membranes can repair themselves while viral membranes cannot. In turn, the researchers believe the compound could be safe for humans, while still effective at killing viruses.

Though LJ001 is nontoxic at doses that kill viruses in animals, more testing will be needed to determine whether it’s safe for humans. The researchers also haven’t yet determined exactly how the compound is able to deactivate the viral membrane.

NEW! Scroll down to comment on this story.

emailrssprint

 

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

  comments 1 - 4 (of 4 total)    

Okonkwo Flavin, Nigeria, 2010-12-26 12:52:31
Bravo that is a great one but i was thinking if red monkeys are investigated more to find out more about their immune to Hiv that may difinitely help

franco, , 2010-08-02 16:51:56
can i come for human testing

Jeton Ademaj, , 2010-02-10 10:44:46
this is a fascinating development. I'm eager to see if such an anti-viral could be additive to current ARV regimens...but i also see a darkside. in case of any widespread epidemics, such a drug would be far more valuable than gold...and anyone thought to possess it would be a target.

nee nee, new york, 2010-02-03 21:44:11
how to prevent wasting when infected with the hiv virus.

comments 1 - 4 (of 4 total)    


[Go to top]

Protesters hold the Hershey Company and its affiliated school accountable for condoning HIV-related discrimination. Click here to read more.
What to do if you've just been diagnosed
Qué hacer si eres recién diagnosticado

How to find a support system
Cómo encontrar un sistema de apoyo

Things you should know before starting treatment
Cosas que deberías saber antes de comenzar un tratamiento

How to handle side effects and other concerns
Cómo tratar los efectos secundarios y otros problemas de salud

How to tell someone you have HIV/AIDS
Cómo revelar tu diagnóstico de VIH/SIDA
[an error occurred while processing this directive]
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.